US Map / Colorado
State CO

Clinical Trials in Colorado

Colorado is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Colorado and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 269 actively recruiting studies with Colorado sites out of 269 registered in total. The busiest research areas in Colorado are Breast Cancer, Aging, Solid Tumor. Leading sponsors running trials in the state include University of Colorado, Denver, Pfizer, AstraZeneca. By stage, Colorado trials break down as Phase 1 (56), Phase 2 (76), Phase 3 (78), Phase 4 (12).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
269
Recruiting Now
269
← Back to US Map
Top Conditions in Colorado
Breast Cancer (5)Aging (4)Solid Tumor (4)Multiple Myeloma (4)Non-Small Cell Lung Cancer (4)Pancreatic Cancer (3)Solid Tumor, Adult (3)Colorectal Neoplasms (3)Urothelial Carcinoma (3)Type 1 Diabetes (3)Cardiovascular Diseases (3)Overweight (3)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 269 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 269. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Aging, Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT07085338 Phase 2
Recruiting
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunot...
Condition
Neuroblastoma Recurrent
Enrollment
54 pts
Location
United States
Sponsor
St. Jude Children's Research H
View Trial →
NCT05266976 N/A
Recruiting
Mode of Exercise and Bone Biomarkers in Older Veterans
Condition
Aging
Enrollment
120 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT06554717 Phase 2
Recruiting
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
Condition
HIV-1-infection
Enrollment
100 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT07361510 Phase 3
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participan...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT07066657 Phase 1
Recruiting
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Condition
Locally Advanced or Metastatic Solid Tumors
Enrollment
572 pts
Location
United States, China
Sponsor
ArriVent BioPharma, Inc.
View Trial →
NCT02540915 N/A
Recruiting
The Pediatric Spine Foundation
Condition
Chest Wall and Spinal Disorders
Enrollment
5,000 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07220876 N/A
Recruiting
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refract...
Condition
Open Angle Glaucoma (OAG)
Enrollment
165 pts
Location
United States, South Africa
Sponsor
Avisi Technologies Inc.
View Trial →
NCT06617325 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Part...
Condition
Systemic Lupus Erythematosus
Enrollment
450 pts
Location
United States, Argentina, Belgium
Sponsor
UCB Biopharma SRL
View Trial →
NCT06471374 N/A
Recruiting
Pathophysiology of Circadian Rhythm Delayed Sleep Wake Phase Disorder
Condition
Delayed Sleep Phase Syndrome
Enrollment
66 pts
Location
United States
Sponsor
University of Colorado, Boulde
View Trial →
NCT06979362 Phase 2
Recruiting
A Research Study Comparing Different Doses of CDR132L With Placebo on the Struct...
Condition
Heart Failure
Enrollment
200 pts
Location
United States, Canada, Germany
Sponsor
Novo Nordisk A/S
View Trial →
NCT07592273 Phase 2, Phase 3
Recruiting
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Particip...
Condition
Diabetic Retinopathy
Enrollment
576 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
View Trial →
NCT07209072 N/A
Recruiting
Emergency Department Linkage to Care for Patients Experiencing Homelessness
Condition
Homelessness
Enrollment
390 pts
Location
United States
Sponsor
Denver Health and Hospital Aut
View Trial →
NCT06127407 Phase 3
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chon...
Condition
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Enrollment
136 pts
Location
United States, Australia, Belgium
Sponsor
Servier Bio-Innovation LLC
View Trial →
NCT06603844 Phase 1, Phase 2
Recruiting
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Condition
Solid Tumor
Enrollment
156 pts
Location
United States, United Kingdom
Sponsor
Corbus Pharmaceuticals Inc.
View Trial →
NCT07200830 Phase 3
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA ...
Condition
Metastatic Castration-Resistant Prostate Carcinoma
Enrollment
1,524 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT03981575 N/A
Recruiting
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Condition
Myotonic Dystrophy 1
Enrollment
700 pts
Location
United States, Canada, Germany
Sponsor
Virginia Commonwealth Universi
View Trial →
NCT05828511 Phase 1, Phase 2
Recruiting
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerat...
Condition
Multiple Myeloma
Enrollment
149 pts
Location
United States, France, Spain
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07160244 Phase 3
Recruiting
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregn...
Condition
Healthy
Enrollment
6,000 pts
Location
United States, Argentina, Brazil
Sponsor
Pfizer
View Trial →
NCT03767595 N/A
Recruiting
ProACT Post-Approval Study
Condition
Stress Urinary Incontinence
Enrollment
145 pts
Location
United States
Sponsor
Uromedica
View Trial →
NCT06947928 Phase 2, Phase 3
Recruiting
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint In...
Condition
Advanced Or Metastatic Merkel Cell Carcinoma
Enrollment
118 pts
Location
United States
Sponsor
TuHURA Biosciences, Inc.
View Trial →
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07165028 Phase 3
Recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associ...
Condition
Metabolic Dysfunction-Associated Steatotic Liver Disease
Enrollment
4,500 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
View Trial →
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
View Trial →
NCT05425992 N/A
Recruiting
Improving Communication and Building a Stronger Medical Home Among Spanish-speak...
Condition
Leukemia
Enrollment
20 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
Page 1 of 11 — 269 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology